Cargando…
Determining the ideal prevention strategy for multidrug-resistance organisms in resource-limited countries: a cost-effectiveness analysis study
The aim of this study was to determine the most cost-effective strategy for the prevention and control of multidrug-resistant organisms (MDROs) in intensive care units (ICUs) in areas with limited health resources. The study was conducted in 12 ICUs of four hospitals. The total cost for the preventi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439291/ https://www.ncbi.nlm.nih.gov/pubmed/32430090 http://dx.doi.org/10.1017/S0950268820001120 |
_version_ | 1783572948604420096 |
---|---|
author | Wang, Ying Yuan, Yufeng Lin, Likai Tan, Xiaodong Tan, Yibin |
author_facet | Wang, Ying Yuan, Yufeng Lin, Likai Tan, Xiaodong Tan, Yibin |
author_sort | Wang, Ying |
collection | PubMed |
description | The aim of this study was to determine the most cost-effective strategy for the prevention and control of multidrug-resistant organisms (MDROs) in intensive care units (ICUs) in areas with limited health resources. The study was conducted in 12 ICUs of four hospitals. The total cost for the prevention of MDROs and the secondary attack rate (SAR) of MDROs for each strategy were collected retrospectively from 2046 subjects from January to December 2017. The average cost-effectiveness ratio (CER), incremental cost-effectiveness ratio (ICER) and cost-effectiveness acceptability curve were calculated. Hand hygiene (HH) had the lowest total cost (2149.6 RMB) and SAR of MDROs (8.8%) while single-room isolation showed the highest cost (33 700.2 RMB) and contact isolation had the highest SAR of MDROs (31.8%). The average cost per unit infection prevention was 24 427.8 RMB, with the HH strategy followed by the environment disinfection strategy (CER = 21 314.67). HH had the highest iterative cost effect under willingness to pay less than 2000 RMB. Due to the low cost for repeatability and obvious effectiveness, we conclude that HH is the optimal strategy for MDROs infections in ICUs in developing countries. The cost-effectiveness of the four prevention strategies provides some reference for developing countries but multiple strategies remain to be examined. |
format | Online Article Text |
id | pubmed-7439291 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-74392912020-09-02 Determining the ideal prevention strategy for multidrug-resistance organisms in resource-limited countries: a cost-effectiveness analysis study Wang, Ying Yuan, Yufeng Lin, Likai Tan, Xiaodong Tan, Yibin Epidemiol Infect Original Paper The aim of this study was to determine the most cost-effective strategy for the prevention and control of multidrug-resistant organisms (MDROs) in intensive care units (ICUs) in areas with limited health resources. The study was conducted in 12 ICUs of four hospitals. The total cost for the prevention of MDROs and the secondary attack rate (SAR) of MDROs for each strategy were collected retrospectively from 2046 subjects from January to December 2017. The average cost-effectiveness ratio (CER), incremental cost-effectiveness ratio (ICER) and cost-effectiveness acceptability curve were calculated. Hand hygiene (HH) had the lowest total cost (2149.6 RMB) and SAR of MDROs (8.8%) while single-room isolation showed the highest cost (33 700.2 RMB) and contact isolation had the highest SAR of MDROs (31.8%). The average cost per unit infection prevention was 24 427.8 RMB, with the HH strategy followed by the environment disinfection strategy (CER = 21 314.67). HH had the highest iterative cost effect under willingness to pay less than 2000 RMB. Due to the low cost for repeatability and obvious effectiveness, we conclude that HH is the optimal strategy for MDROs infections in ICUs in developing countries. The cost-effectiveness of the four prevention strategies provides some reference for developing countries but multiple strategies remain to be examined. Cambridge University Press 2020-05-20 /pmc/articles/PMC7439291/ /pubmed/32430090 http://dx.doi.org/10.1017/S0950268820001120 Text en © The Author(s) 2020 http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Paper Wang, Ying Yuan, Yufeng Lin, Likai Tan, Xiaodong Tan, Yibin Determining the ideal prevention strategy for multidrug-resistance organisms in resource-limited countries: a cost-effectiveness analysis study |
title | Determining the ideal prevention strategy for multidrug-resistance organisms in resource-limited countries: a cost-effectiveness analysis study |
title_full | Determining the ideal prevention strategy for multidrug-resistance organisms in resource-limited countries: a cost-effectiveness analysis study |
title_fullStr | Determining the ideal prevention strategy for multidrug-resistance organisms in resource-limited countries: a cost-effectiveness analysis study |
title_full_unstemmed | Determining the ideal prevention strategy for multidrug-resistance organisms in resource-limited countries: a cost-effectiveness analysis study |
title_short | Determining the ideal prevention strategy for multidrug-resistance organisms in resource-limited countries: a cost-effectiveness analysis study |
title_sort | determining the ideal prevention strategy for multidrug-resistance organisms in resource-limited countries: a cost-effectiveness analysis study |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439291/ https://www.ncbi.nlm.nih.gov/pubmed/32430090 http://dx.doi.org/10.1017/S0950268820001120 |
work_keys_str_mv | AT wangying determiningtheidealpreventionstrategyformultidrugresistanceorganismsinresourcelimitedcountriesacosteffectivenessanalysisstudy AT yuanyufeng determiningtheidealpreventionstrategyformultidrugresistanceorganismsinresourcelimitedcountriesacosteffectivenessanalysisstudy AT linlikai determiningtheidealpreventionstrategyformultidrugresistanceorganismsinresourcelimitedcountriesacosteffectivenessanalysisstudy AT tanxiaodong determiningtheidealpreventionstrategyformultidrugresistanceorganismsinresourcelimitedcountriesacosteffectivenessanalysisstudy AT tanyibin determiningtheidealpreventionstrategyformultidrugresistanceorganismsinresourcelimitedcountriesacosteffectivenessanalysisstudy |